全文获取类型
收费全文 | 1157篇 |
免费 | 61篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 14篇 |
妇产科学 | 5篇 |
基础医学 | 123篇 |
口腔科学 | 20篇 |
临床医学 | 62篇 |
内科学 | 393篇 |
皮肤病学 | 25篇 |
神经病学 | 57篇 |
特种医学 | 100篇 |
外科学 | 147篇 |
综合类 | 4篇 |
预防医学 | 41篇 |
眼科学 | 4篇 |
药学 | 140篇 |
中国医学 | 2篇 |
肿瘤学 | 76篇 |
出版年
2023年 | 14篇 |
2022年 | 15篇 |
2021年 | 31篇 |
2020年 | 17篇 |
2019年 | 22篇 |
2018年 | 29篇 |
2017年 | 17篇 |
2016年 | 17篇 |
2015年 | 30篇 |
2014年 | 25篇 |
2013年 | 36篇 |
2012年 | 61篇 |
2011年 | 65篇 |
2010年 | 35篇 |
2009年 | 21篇 |
2008年 | 57篇 |
2007年 | 58篇 |
2006年 | 61篇 |
2005年 | 63篇 |
2004年 | 49篇 |
2003年 | 50篇 |
2002年 | 56篇 |
2001年 | 61篇 |
2000年 | 41篇 |
1999年 | 34篇 |
1998年 | 11篇 |
1997年 | 9篇 |
1996年 | 7篇 |
1994年 | 7篇 |
1993年 | 7篇 |
1992年 | 26篇 |
1991年 | 16篇 |
1990年 | 17篇 |
1989年 | 12篇 |
1988年 | 14篇 |
1987年 | 13篇 |
1986年 | 14篇 |
1985年 | 12篇 |
1984年 | 8篇 |
1983年 | 15篇 |
1982年 | 4篇 |
1980年 | 5篇 |
1979年 | 7篇 |
1974年 | 5篇 |
1973年 | 6篇 |
1972年 | 12篇 |
1971年 | 7篇 |
1970年 | 3篇 |
1968年 | 3篇 |
1966年 | 3篇 |
排序方式: 共有1225条查询结果,搜索用时 31 毫秒
101.
102.
Thoracoscopy-assisted magnetic resonance guided microwave coagulation therapy for hepatic tumors 总被引:1,自引:1,他引:0
Shiomi H Naka S Sato K Demura K Murakami K Shimizu T Morikawa S Kurumi Y Tani T 《American journal of surgery》2008,195(6):854-860
BACKGROUND: Microwave coagulation therapy (MCT) has become a safe and effective modality with which to treat hepatic tumors; MCT can be applied percutaneously, laparoscopically, thoracoscopically, and during laparotomy. When combined with magnetic resonance (MR) imaging, MCT can be used to treat hepatic tumors located in the subdiaphragmatic area that are difficult to approach by ultrasound, because of the overlaying lower lung field. METHODS: To determine the usefulness of thoracoscopy-assisted interventional MR-MCT (T-IVMR-MCT, n = 73), we compared patients with hepatic tumors that were treated with percutaneous IVMR-MCT (P-IVMR-MCT, n = 69) and with T-IVMR-MCT. RESULTS: None of patient background, complication and recurrence rate, or length of hospital stay significantly differed between the 2 groups. CONCLUSIONS: IVMR-MCT is a useful modality for treating hepatic tumors. Especially when tumors are located at the hepatic dome, T-IVMR-MCT was minimally invasive, while it appears to improve targeting of peridiagmatic hepatic lesions and has a complication profile similar to P-IVMR-MCT. 相似文献
103.
Diagnostic biomarker of asbestos-related mesothelioma: example of translational research 总被引:1,自引:0,他引:1
Mesothelioma is an aggressive tumor arising from the mesothelium, and is usually associated with previous exposure to asbestos. The incubation period of asbestos-related mesothelioma is estimated to be approximately 30-40 years. Once mesothelioma has occurred, there is no effective treatment. So, identification of tumor markers and a method for early diagnosis using such markers are urgently needed. Recently, several enzyme-linked immunosorbent assay systems for Erc/mesothelin have been developed, the reported usefulness of which has been assessed and demonstrated as a diagnostic tool. Asbestos-related mesothelioma should be ascribed as a typical environmental carcinogen. In this review, we will present asbestos-related mesothelioma for the study of problems in environmental carcinogenesis. 相似文献
104.
105.
Oh S Miyamoto H Yamazaki A Fukai R Shiomi K Sonobe S Saito Y Sakuraba M Futagawa T Sakao Y 《General thoracic and cardiovascular surgery》2007,55(3):119-124
Objectives The psychological effects of surgery have received little attention in patients with lung cancer, so it is unclear how much
psychological support is required by these patients. This study was done to assess the mental state of patients with lung
cancer before and after surgery and to determine their need for psychological care.
Methods A group of 165 patients with lung cancer scheduled for surgical treatment were included in this study. They were asked to
complete the Profile of Mood States questionnaire before surgery and on discharge after completion of treatment. The data
on mood from the questionnaires were analyzed.
Results Tension-anxiety improved significantly after surgery, whereas the fatigue score increased significantly. The scores for depression-dejection
and confusion were elevated before surgery and were unchanged afterward.
Conclusions Patients with lung cancer were depressed before surgery and remained depressed after their operations, although postoperative
tension-anxiety diminished. These results indicate that lung cancer patients need psychological support to alleviate depression
during the perioperative period. 相似文献
106.
107.
M Kuroda A Matsumoto H Itakura Y Watanabe T Ito M Shiomi J Fukushige F Nara M Fukami Y Tsujita 《Japanese journal of pharmacology》1992,59(1):65-70
Pravastatin sodium (pravastatin), a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, was administered alone (50 mg/kg) or in combination with cholestyramine, a bile acid sequestrant resin, at the level of 2% in the diet to homozygous Watanabe heritable hyperlipidemic (WHHL) rabbits for 4 weeks. The low density lipoprotein (LDL)-cholesterol levels were reduced by 29% and 56% with pravastatin alone and the combination treatment, respectively. Hepatic LDL receptor activity was increased by 11.2- and 13.9-fold with pravastatin alone and the combination treatment, respectively. The LDL receptor activity in the untreated homozygous WHHL rabbits was only 2.5% of that in the normal rabbits. mRNA for the LDL receptor in the liver was also increased by 2.1- and 3.4-fold with pravastatin alone and the combination treatment, respectively. On the other hand, mRNA for the LDL receptor in the adrenal gland was not affected by pravastatin and the combination treatment, whereas the mRNA in the intestine was increased in both groups. These results suggest the following: 1) the induction of hepatic LDL receptor activity by the treatment of pravastatin alone or in combination with cholestyramine is the main cause of the reduction of serum cholesterol levels by these treatments even in LDL receptor-deficient animals. 2) The induction of the mRNA for the LDL receptor in the liver and intestine, but not that in the adrenal gland, might be a reflection of the tissue-selective inhibition of cholesterol synthesis by pravastatin. 相似文献
108.
Yukinori Sakao Hideaki Miyamoto Akio Yamazaki Shiaki Ou Kazu Shiomi Satoshi Sonobe Motoki Sakuraba 《European journal of cardio-thoracic surgery》2006,30(3):543-547
BACKGROUND: This study endeavored to clarify the location, frequency, and prognostic value of metastatic lymph nodes in the mediastinum among patients with left upper lung cancer who underwent complete dissection of the superior mediastinal lymph node through a median sternotomy. METHODS: Forty-four patients with left upper lobe cancer underwent extended radical mediastinal nodal dissection (ERD), all of whom were analyzed in this retrospective study. The group comprised 12 females and 32 males, with ages ranging from 28 to 70 years (median age, 60 years). Mediastinal nodal status was assessed according to the systems of Mountain/Dresler 7 and Naruke 8. The clinicopathological records of each patient were examined for prognostic factors, including age, sex, histology, tumor size, c-N number, preoperative serum CEA level, metastatic stations and distribution of metastatic nodes according to Naruke's system 8. The superior mediastinal lymph nodes which cannot be dissected through a left thoracotomy (bilateral #1 and #2, #3, right #3a, and right #4 according to Naruke's map 8 were defined as extra-superior mediastinal nodes for left lung cancer (ESMD). RESULTS: Fourteen patients had one or more metastases to mediastinal lymph nodes, among whom the most common metastatic station was the aortic nodes: 71.4% had metastasis to #5 or #6 (57.1% to #5 and 50% to #6). The next most common metastatic station was the left tracheobronchial nodes (42.8%). Metastasis to the ESMD occurred in 7 of the 44 study subjects (16%), representing a 50% rate of occurrence (7/14) among those with mediastinal nodal involvement. Univariate analysis found that CN factor and aortic nodal involvement (#5, #6) were significant predictive factors for ESMD metastasis. Multivariate analysis determined that only aortic nodal involvement was significant (p = 0.008). Furthermore, ESMD metastasis was rare (5.8%) in the absence of aortic node metastasis. The overall survival rate at 5 years was 50% among the patients without ESMD metastasis. However, the survival rate was 32% at 3 years and 0% at 5 years among the seven patients with ESMD metastasis. CONCLUSIONS: The aortic lymph node is the most common site of metastasis from left upper lobe cancer. Multivariate analysis demonstrated that aortic nodal involvement was a significant predictive factor for ESMD metastasis. Based upon the rates of metastasis and the post-operative prognosis in our study patients, dissection of aortic nodes and left tracheobronchial nodes may be important for patients with left upper lobe cancer. Whether ESMD dissection has a beneficial effect on prognosis remains controversial. 相似文献
109.
110.
Mayu Shiomi Shinya Matsuzaki Satoshi Serada Koji Matsuo Chihiro Mizuta-Odani Mariko Jitsumori Ruriko Nakae Satoko Matsuzaki Satoshi Nakagawa Kosuke Hiramatsu Ai Miyoshi Eiji Kobayashi Toshihiro Kimura Yutaka Ueda Kiyoshi Yoshino Tetsuji Naka Tadashi Kimura 《Cancer science》2021,112(9):3655-3668
This study aimed to investigate the cytotoxicity of a cluster of differentiation 70 antibody-drug conjugate (CD70-ADC) against ovarian cancer in in vitro and in vivo xenograft models. CD70 expression was assessed in clinical samples by immunohistochemical analysis. Western blotting and fluorescence-activated cell sorting analyses were used to determine CD70 expression in the ovarian cancer cell lines A2780 and SKOV3, and in the cisplatin-resistant ovarian cancer cell lines A2780cisR and SKOV3cisR. CD70 expression after cisplatin exposure was determined in A2780 cells transfected with mock- or nuclear factor (NF)-κB-p65-small interfering RNA. We developed an ADC with an anti-CD70 monoclonal antibody linked to monomethyl auristatin F and investigated its cytotoxic effect. We examined 63 ovarian cancer clinical samples; 43 (68.3%) of them expressed CD70. Among patients with advanced stage disease (n = 50), those who received neoadjuvant chemotherapy were more likely to exhibit high CD70 expression compared to those who did not (55.6% [15/27] vs 17.4% [4/23], P < .01). CD70 expression was confirmed in A2780cisR, SKOV3, and SKOV3cisR cells. Notably, CD70 expression was induced after cisplatin treatment in A2780 mock cells but not in A2780-NF-κB-p65-silenced cells. CD70-ADC was cytotoxic to A2780cisR, SKOV3, and SKOV3cisR cells, with IC50 values ranging from 0.104 to 0.341 nmol/L. In A2780cisR and SKOV3cisR xenograft models, tumor growth in CD70-ADC treated mice was significantly inhibited compared to that in the control-ADC treated mice (A2780cisR: 32.0 vs 1639.0 mm3, P < .01; SKOV3cisR: 232.2 vs 584.9 mm3, P < .01). Platinum treatment induced CD70 expression in ovarian cancer cells. CD70-ADC may have potential therapeutic implications in the treatment of CD70 expressing ovarian cancer. 相似文献